Associated Papers
Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature.
van der Wekken AJ et al.
Critical Reviews in Oncology/hematology, 2016
Select a paper to view details